MRNA shares fell 2.4% to $54.49 at the July 29, 2026 close, a modest decline from the prior close of $55.81. That close is the latest confirmed price for MRNA; a live quote was not available. BestStocks flagged the session as a major change for MRNA. The move is tied to price move down. Below, we break down what changed for MRNA, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
What happened
MRNA fell 2.4% to $54.49
MRNA fell 2.4% in its latest session, moving from $55.81 to $54.49.
Material / EarningsWeak confidence
Rel. volume
—
Calculating
Vs peers
—
No comparable peers
Market cap
—
Earnings in
0d
2026-07-31
Price chart
Jun 30 – Jul 31
E earnings
F filing
A analyst
V/N other
click a marker to highlight
Change events — click to jump to details
What it means for MRNA investors
For MRNA investors, the recent signals add up to a bearish shift. On the constructive side: Moderna, Inc. (MRNA) moved +3.74% from $73.80 to $76.56 on 2026-07-09; Moderna, Inc. (MRNA) moved +2.56% from $79.76 to $81.80 on 2026-07-06, reaching a new 30-day high. Weighing against that: Material negative event; Negative session, down 2.4%. BestStocks rates the overall signal quality weak (37/100). With earnings due imminently, the next report is the most likely near-term test of the move.
MRNA price reaction
MRNA last traded at $54.49, down $1.32 (-2.37%) from the previous close of $55.81. Over the past month the stock has ranged between $54.07 and $81.80, and it currently sits about 2% of the way up that band.
The bull and bear case for MRNA stock
Weighing the constructive signals against the risks, here is how the bull and bear case for MRNA lines up on the latest data.
▲ The bullish case
+Moderna, Inc. (MRNA) moved +3.74% from $73.80 to $76.56 on 2026-07-09.
▼ The bearish case
−Material negative event.
−Negative session, down 2.4%.
−Moderna, Inc. (MRNA) moved -3.77% from $61.82 to $59.49 on 2026-07-20.
Bull vs bear balanceBearish Shift
BearishNeutralBullish
Weighing both sides, BestStocks' composite read of recent signals is bearish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Moderna, Inc. (MRNA) moved -0.21% from $57.14 to $57.02 on 2026-07-23. We checked news, earnings announcements, analyst updates, filings, and corporate actions — no company-specific catalyst was found. The move occurred as MRNA reached a new 30-day low on volume near its 5-day average.
Activity2026-07-22-2.7%
Moderna, Inc. (MRNA) moved -2.67% from $59.66 to $58.07 on 2026-07-22. We checked news, earnings, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The move coincided with MRNA reaching a new 30-day low; volume remained near its 5-day average.
Risk2026-07-20-3.8%
Moderna, Inc. (MRNA) moved -3.77% from $61.82 to $59.49 on 2026-07-20. We checked news, earnings, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was near its 5-day average, suggesting the decline occurred on relatively typical trading activity.
Risk2026-07-16-7.5%
Moderna, Inc. (MRNA) moved -7.51% from $68.28 to $63.15 on 2026-07-16. We checked news, earnings, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was near its 5-day average, indicating the move was not driven by unusual trading activity.
Risk2026-07-10-10.8%
Moderna, Inc. (MRNA) moved -10.83% from $76.56 to $68.27 on 2026-07-10. We checked news, earnings, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was near its 5-day average, indicating the move occurred without unusual trading activity.
Activity2026-07-09+3.7%
Moderna, Inc. (MRNA) moved +3.74% from $73.80 to $76.56 on 2026-07-09. We checked news, earnings, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found.
Moderna, Inc. moved -7.06% intraday from $81.80 to $76.03. Moderna Appoints Michael McDonnell to Board of Directors: Former Biogen Chief Financial Officer brings more than 35 years of financial leadership and public company experience CAMBRIDGE, MA / ACCESS Newswire / July 8, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced the appoi [2026-07-08]
Filings2026-07-08-7.5%
MRNA filed a new 8-K on 2026-07-08.
Upcoming catalysts & outlook
Next earnings
2026-07-31
in 0 days
Thesis shift
Bearish Shift
bearish signal
Risk level
High
from change events
Frequently asked questions about MRNA
Why did MRNA stock move?
MRNA fell 2.4% to $54.49. No single company-specific catalyst was confirmed during the move window, and it looks technical.
How much did MRNA stock fall?
MRNA lost 2.37% ($1.32) versus the prior close of $55.81, last trading at $54.49.
When is MRNA's next earnings date?
MRNA's next earnings report is scheduled for 2026-07-31 — about 0 days away.
How BestStocks tracks MRNA
This page is generated automatically by BestStocks' change-detection system after price move down was detected and verified against independent data sources. It draws on 14 tracked change events for MRNA, cross-checked against the data sources listed below. A live intraday quote was not available, so price and volume figures are the confirmed end-of-day close from July 29, 2026 — not the current price — and the percentage move is that session's. They refresh once live quotes resume. For companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.
